ADUS Stock — Addus HomeCare Corporation

Addus HomeCare Corporation (ADUS)

Updated October 16, 2026.

ADUS is a Stock. Total return is 1266.1% over the past 17 years, 378.8 points ahead of SPY at 887.3%.

Addus HomeCare Corporation operates a healthcare services business providing personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals across the United States, serving government agencies, managed care organizations, insurers, and private individuals. The company's distribution profile is not currently known. This business appeals to investors seeking exposure to the healthcare services sector.

ADUS performance versus SPY

Price and return data through 2026-10-16.

Total return is 1266.1% over the past 17 years, 378.8 points ahead of SPY at 887.3%. Over the past year its total return — price change plus distributions reinvested — is -1.0%. Its deepest 1-year drawdown was 27.9%.

ADUS key facts

Asset type

Stock

Asset class

Equity

Inception date

10/28/2009

Distribution frequency

None

Last close

$115.98 (as of 2026-10-16)

Market cap

$2,164,740,720

Average volume

136879.0

Beta

0.83

Payout ratio

0.0%

P/E ratio

20.31

Forward P/E

15.1515

EPS

$5.71

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

ADUS risks and drawbacks

The deepest 1-year drawdown on record here is 27.9%.

Who may consider ADUS — and who may not

It is a weaker fit for investors who need monthly cash flow (ADUS does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on ADUS

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions